Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 30, 2022
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: August 28, 2020
Corrigendum to Intracerebral Hemorrhage in Multiple Sclerosis: A Retrospective Cohort Study [Journal of Stroke and Cerebrovascular Diseases Volume 28, Issue 2, February 2019, Pages 267-275].
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: February 13, 2019
Intracerebral Hemorrhage in Multiple Sclerosis: A Retrospective Cohort Study.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: June 15, 2018
Projecting the Adequacy of the Multiple Sclerosis Neurologist Workforce.
Journal: International journal of MS care
Published: March 07, 2018
Cultivating the Multiple Sclerosis Workforce of the Future.
Journal: International journal of MS care
Published: June 13, 2017
The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension Study.
Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging
Published: February 02, 2016
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
Journal: AJNR. American journal of neuroradiology
Published: November 14, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Journal: The Lancet. Neurology
Published: June 02, 2015
Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.
Journal: Expert review of neurotherapeutics
Published: May 01, 2015
Investigation of blast-induced traumatic brain injury.
Journal: Brain injury
Published: April 29, 2014
Last Updated: 09/26/2026